Cargando…
Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition
Myeloid neoplasms (MN) with germline predisposition (MNGP) are likely to be more common than currently appreciated. Many of the genes involved in MNGP are also recurrently mutated in sporadic MN. Therefore, routine analysis of gene panels by next‐generation sequencing provides an effective approach...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410541/ https://www.ncbi.nlm.nih.gov/pubmed/33533142 http://dx.doi.org/10.1002/1878-0261.12921 |
_version_ | 1783747133813293056 |
---|---|
author | Andrés‐Zayas, Cristina Suárez‐González, Julia Rodríguez‐Macías, Gabriela Dorado, Nieves Osorio, Santiago Font, Patricia Carbonell, Diego Chicano, María Muñiz, Paula Bastos, Mariana Kwon, Mi Díez‐Martín, José Luis Buño, Ismael Martínez‐Laperche, Carolina |
author_facet | Andrés‐Zayas, Cristina Suárez‐González, Julia Rodríguez‐Macías, Gabriela Dorado, Nieves Osorio, Santiago Font, Patricia Carbonell, Diego Chicano, María Muñiz, Paula Bastos, Mariana Kwon, Mi Díez‐Martín, José Luis Buño, Ismael Martínez‐Laperche, Carolina |
author_sort | Andrés‐Zayas, Cristina |
collection | PubMed |
description | Myeloid neoplasms (MN) with germline predisposition (MNGP) are likely to be more common than currently appreciated. Many of the genes involved in MNGP are also recurrently mutated in sporadic MN. Therefore, routine analysis of gene panels by next‐generation sequencing provides an effective approach to detect germline variants with clinical significance in patients with hematological malignancies. Gene panel sequencing was performed in 88 consecutive and five nonconsecutive patients with MN diagnosis. Disease‐causing germline mutations in CEBPα, ASXL1, TP53, MPL, GATA2, DDX41, and ETV6 genes were identified in nine patients. Six out of the nine patients with germline variants had a strong family history. These patients presented great heterogeneity in the age of diagnosis and phenotypic characteristics. In our study, there were families in which all the affected members presented the same subtype of disease, whereas members of other families presented various disease phenotypes. This intrafamiliar heterogeneity suggests that the acquisition of particular somatic variants may drive the evolution of the disease. This approach enabled high‐throughput detection of MNGP in patients with MN diagnosis, which is of great relevance for both the patients themselves and the asymptomatic mutation carriers within the family. It is crucial to make a proper diagnosis of these patients to provide them with the most suitable treatment, follow‐up, and genetic counseling. |
format | Online Article Text |
id | pubmed-8410541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84105412021-09-03 Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition Andrés‐Zayas, Cristina Suárez‐González, Julia Rodríguez‐Macías, Gabriela Dorado, Nieves Osorio, Santiago Font, Patricia Carbonell, Diego Chicano, María Muñiz, Paula Bastos, Mariana Kwon, Mi Díez‐Martín, José Luis Buño, Ismael Martínez‐Laperche, Carolina Mol Oncol Research Articles Myeloid neoplasms (MN) with germline predisposition (MNGP) are likely to be more common than currently appreciated. Many of the genes involved in MNGP are also recurrently mutated in sporadic MN. Therefore, routine analysis of gene panels by next‐generation sequencing provides an effective approach to detect germline variants with clinical significance in patients with hematological malignancies. Gene panel sequencing was performed in 88 consecutive and five nonconsecutive patients with MN diagnosis. Disease‐causing germline mutations in CEBPα, ASXL1, TP53, MPL, GATA2, DDX41, and ETV6 genes were identified in nine patients. Six out of the nine patients with germline variants had a strong family history. These patients presented great heterogeneity in the age of diagnosis and phenotypic characteristics. In our study, there were families in which all the affected members presented the same subtype of disease, whereas members of other families presented various disease phenotypes. This intrafamiliar heterogeneity suggests that the acquisition of particular somatic variants may drive the evolution of the disease. This approach enabled high‐throughput detection of MNGP in patients with MN diagnosis, which is of great relevance for both the patients themselves and the asymptomatic mutation carriers within the family. It is crucial to make a proper diagnosis of these patients to provide them with the most suitable treatment, follow‐up, and genetic counseling. John Wiley and Sons Inc. 2021-07-16 2021-09 /pmc/articles/PMC8410541/ /pubmed/33533142 http://dx.doi.org/10.1002/1878-0261.12921 Text en © 2021 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Andrés‐Zayas, Cristina Suárez‐González, Julia Rodríguez‐Macías, Gabriela Dorado, Nieves Osorio, Santiago Font, Patricia Carbonell, Diego Chicano, María Muñiz, Paula Bastos, Mariana Kwon, Mi Díez‐Martín, José Luis Buño, Ismael Martínez‐Laperche, Carolina Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition |
title | Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition |
title_full | Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition |
title_fullStr | Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition |
title_full_unstemmed | Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition |
title_short | Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition |
title_sort | clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410541/ https://www.ncbi.nlm.nih.gov/pubmed/33533142 http://dx.doi.org/10.1002/1878-0261.12921 |
work_keys_str_mv | AT andreszayascristina clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT suarezgonzalezjulia clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT rodriguezmaciasgabriela clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT doradonieves clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT osoriosantiago clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT fontpatricia clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT carbonelldiego clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT chicanomaria clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT munizpaula clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT bastosmariana clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT kwonmi clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT diezmartinjoseluis clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT bunoismael clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition AT martinezlaperchecarolina clinicalutilityoftargetednextgenerationsequencingforthediagnosisofmyeloidneoplasmswithgermlinepredisposition |